INTEGRATED BIOPHARMA INC Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Integrated Biopharma Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2021.
  • Integrated Biopharma Inc Share-based Payment Arrangement, Expense for the quarter ending March 31, 2022 was $49K, a 47.9% decline year-over-year.
  • Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2021 was $231K, a 292% increase from 2020.
  • Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2020 was $59K, a 59% decline from 2019.
  • Integrated Biopharma Inc annual Share-based Payment Arrangement, Expense for 2019 was $144K, a 929% increase from 2018.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $231K +$172K +292% Jul 1, 2020 Jun 30, 2021 10-K 2021-09-02
2020 $59K -$85K -59% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-02
2019 $144K +$130K +929% Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
2018 $14K -$35K -71.4% Jul 1, 2017 Jun 30, 2018 10-K 2019-08-29
2017 $49K +$18K +58.1% Jul 1, 2016 Jun 30, 2017 10-K 2018-09-12
2016 $31K -$69K -69% Jul 1, 2015 Jun 30, 2016 10-K 2017-09-01
2015 $100K +$100K Jul 1, 2014 Jun 30, 2015 10-K 2016-09-02
2014 $0 $0 Jul 1, 2013 Jun 30, 2014 10-K 2015-09-04
2013 $0 Jul 1, 2012 Jun 30, 2013 10-K 2014-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.